Alexander Dobrovic

Credit Name
Alexander Dobrovic
Full Name
Dobrovic, Alexander
 
 
Twitter
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false

Publications

Refined By:
Date Issued:  [2020 TO 2024]
Author:  Scott, Clare L

Results 1-7 of 7 (Search time: 0.008 seconds).

Publication YearTitleAuthor(s)
12024The role of aberrant DNA methylation in cancer initiation and clinical impacts.Geissler, Franziska; Nesic, Ksenija; Kondrashova, Olga; Dobrovic, Alexander ; Swisher, Elizabeth M; Scott, Clare L; J Wakefield, Matthew
24-May-2023Targeting homologous recombination deficiency in uterine leiomyosarcomaDall, Genevieve; Vandenberg, Cassandra J; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H A; BedÅ‘, Justin; Penington, Jocelyn; Wakefield, Matthew J; Kee, Damien ; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P; Dobrovic, Alexander ; Fox, Stephen B; McNally, Orla; Power, Jeremy D; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M; Klein, Oliver ; Barnett, Stephen A ; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T; Scott, Clare L; Barker, Holly E
32023The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models.Ho, Gwo Yaw; Vandenberg, Cassandra J; Lim, Ratana; Christie, Elizabeth L; Garsed, Dale W; Lieschke, Elizabeth; Nesic, Ksenija; Kondrashova, Olga; Ratnayake, Gayanie; Radke, Marc; Penington, Jocelyn S; Carmagnac, Amandine; Heong, Valerie; Kyran, Elizabeth L; Zhang, Fan; Traficante, Nadia; Huang, Ruby; Dobrovic, Alexander ; Swisher, Elizabeth M; McNally, Orla; Kee, Damien ; Wakefield, Matthew J; Papenfuss, Anthony T; Bowtell, David D L; Barker, Holly E; Scott, Clare L
415-Sep-2021Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma.Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Ghamsari, Mohammad Reza Eftekhariyan; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Australian Ovarian Cancer Study, null; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L
5Sep-2021Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.Hurley, Rachel M; McGehee, Cordelia D; Nesic, Ksenija; Correia, Cristina; Weiskittel, Taylor M; Kelly, Rebecca L; Venkatachalam, Annapoorna; Hou, Xiaonan; Pathoulas, Nicholas M; Meng, X Wei; Kondrashova, Olga; Radke, Marc R; Schneider, Paula A; Flatten, Karen S; Peterson, Kevin L; Becker, Marc A; Wong, Ee Ming; Southey, Melissa S; Dobrovic, Alexander ; Lin, Kevin K; Harding, Thomas C; McNeish, Iain; Ross, Christian A; Wagner, Jill M; Wakefield, Matthew J; Scott, Clare L; Haluska, Paul; Wahner Hendrickson, Andrea E; Karnitz, Larry M; Swisher, Elizabeth M; Li, Hu; Weroha, S John; Kaufmann, Scott H
628-Jul-2021Acquired RAD51C promoter methylation loss causes PARP inhibitor resistance in high grade serous ovarian carcinoma.Nesic, Ksenija; Kondrashova, Olga; Hurley, Rachel M; McGehee, Cordelia D; Vandenberg, Cassandra J; Ho, Gwo-Yaw; Lieschke, Elizabeth; Dall, Genevieve; Bound, Nirashaa; Shield-Artin, Kristy; Radke, Marc; Musafer, Ashan; Chai, Zi Qing; Eftekhariyan Ghamsari, Mohammad Reza; Harrell, Maria I; Kee, Damien ; Olesen, Inger; McNally, Orla; Traficante, Nadia; Cancer Study, Australian Ovarian; DeFazio, Anna; Bowtell, David D L; Swisher, Elizabeth M; Weroha, S John; Nones, Katia; Waddell, Nicola; Kaufmann, Scott H; Dobrovic, Alexander ; Wakefield, Matthew J; Scott, Clare L
73-May-2021Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2).Swisher, Elizabeth M; Kwan, Tanya T; Oza, Amit M; Tinker, Anna V; Ray-Coquard, Isabelle; Oaknin, Ana; Coleman, Robert L; Aghajanian, Carol; Konecny, Gottfried E; O'Malley, David M; Leary, Alexandra; Provencher, Diane; Welch, Stephen; Chen, Lee-May; Wahner Hendrickson, Andrea E; Ma, Ling; Ghatage, Prafull; Kristeleit, Rebecca S; Dorigo, Oliver; Musafer, Ashan; Kaufmann, Scott H; Elvin, Julia A; Lin, Douglas I; Chambers, Setsuko K; Dominy, Erin; Vo, Lan-Thanh; Goble, Sandra; Maloney, Lara; Giordano, Heidi; Harding, Thomas; Dobrovic, Alexander ; Scott, Clare L; Lin, Kevin K; McNeish, Iain A